CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $395,614
- in 3 filings
Net −$395,614. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-14 | Wilson Martin General Counsel | Option exercise · Restricted Stock Units | −9,712 | 19,367 | ||
| 2024-02-14 | Shah Gaurav CEO | Option exercise | −46,828 | 575,034 | ||
| 2024-02-14 | Shah Gaurav CEO | Option exercise · Restricted Stock Units | −7,979 | 31,919 | ||
| 2024-02-14 | Shah Gaurav CEO | Option exercise · Restricted Stock Units | −38,849 | 77,468 | ||
| 2024-02-14 | Patel Kinnari See Remarks | Option exercise | +26,189 | 245,478 | ||
| 2024-02-14 | Patel Kinnari See Remarks | Option exercise · Restricted Stock Units | −3,990 | 15,960 | ||
| 2024-02-14 | Patel Kinnari See Remarks | Option exercise · Restricted Stock Units | −22,199 | 44,268 | ||
| 2024-02-14 | Militello John See Remarks | Option exercise | +6,274 | 16,433 | ||
| 2024-02-14 | Militello John See Remarks | Option exercise · Restricted Stock Units | −725 | 2,903 | ||
| 2024-02-14 | Militello John See Remarks | Option exercise · Restricted Stock Units | −5,549 | 10,159 | ||
| 2024-01-22 | Militello John See Remarks | Sale | −638 | $27.20 | $17K | 10,159 |
| 2024-01-18 | Militello John See Remarks | Option exercise | +1,586 | 10,797 | ||
| 2024-01-18 | Militello John See Remarks | Option exercise · Restricted Stock Units | −1,586 | 7,932 | ||
| 2023-12-07 | Woods Keith Director | Grant or award · Stock Option (Right to Buy) | +20,522 | 20,522 | ||
| 2023-12-07 | Woods Keith Director | Grant or award · Stock Option (Right to Buy) | +11,960 | 11,960 | ||
| 2023-11-15 | Makker Gotham Director | Sale | −20,000 | $22.53 | $451K | 1,296,497 |
| 2023-11-14 | Patel Kinnari See Remarks | Option exercise | +3,989 | 220,437 | ||
| 2023-11-14 | Patel Kinnari See Remarks | Option exercise · Restricted Stock Units | −3,989 | 19,950 | ||
| 2023-11-14 | Shah Gaurav CEO | Option exercise | −7,979 | 532,833 | ||
| 2023-11-14 | Shah Gaurav CEO | Option exercise · Restricted Stock Units | −7,979 | 39,898 |
Page 13 of 19 · 374 trades